Marathon Capital Management Johnson & Johnson Transaction History

Marathon Capital Management

$399 Million
Q3 2024

A detailed history of Marathon Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Marathon Capital Management holds 29,699 shares of JNJ stock, worth $4.29 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

29,699

Previous 29,668 0.1%

Holding current value

$4.29 Million

Previous $4.34 Million 11.0%

% of portfolio

1.21%

Previous 1.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $4,509 - $5,188	31 Added 0.1%	29,699 $4.81 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $135,717 - $148,313	940 Added 3.27%	29,668 $4.34 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $26,076 - $27,340	168 Added 0.59%	28,728 $4.54 Million
Q4 2023 Feb 08, 2024	BUY	$145.6 - $158.88 $25,625 - $27,962	176 Added 0.62%	28,560 $4.48 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $1.18 Million - $1.32 Million	-7,590 Reduced 21.1%	28,384 $4.42 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $58,498 - $62,955	-379 Reduced 1.04%	35,974 $5.95 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $86,400 - $103,108	-572 Reduced 1.55%	36,353 $5.63 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $2,563 - $2,876	-16 Reduced 0.04%	36,925 $6.52 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $1.7 Million - $1.89 Million	10,542 Added 39.93%	36,941 $6.04 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $12,277 - $13,578	-73 Reduced 0.28%	26,399 $4.69 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $3,637 - $4,130	-23 Reduced 0.09%	26,472 $4.69 Million
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $119,910 - $133,044	-769 Reduced 2.82%	26,495 $4.53 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $193,800 - $215,364	1,200 Added 4.6%	27,264 $4.4 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $67,460 - $72,362	-423 Reduced 1.6%	26,064 $4.29 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $141,130 - $157,182	922 Added 3.61%	26,487 $4.35 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $65,127 - $74,755	-475 Reduced 1.82%	25,565 $4.02 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $251,420 - $275,509	-1,791 Reduced 6.44%	26,040 $3.88 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $2,705 - $3,265	-21 Reduced 0.08%	27,831 $3.91 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $132,590 - $183,710	-1,193 Reduced 4.11%	27,852 $3.65 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $846,600 - $972,361	6,640 Added 29.64%	29,045 $4.24 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $37,831 - $42,357	-298 Reduced 1.31%	22,405 $2.9 Million
Q2 2019 Jul 25, 2019	BUY	$131.15 - $144.24 $31,738 - $34,906	242 Added 1.08%	22,703 $3.16 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $45,636 - $50,743	-363 Reduced 1.59%	22,461 $3.14 Million
Q4 2018 Feb 07, 2019	SELL	$122.84 - $147.84 $125,419 - $150,944	-1,021 Reduced 4.28%	22,824 $2.95 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $57,628 - $67,725	-474 Reduced 1.95%	23,845 $3.29 Million
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $128,355 - $141,642	-1,075 Reduced 4.23%	24,319 $2.95 Million
Q1 2018 May 07, 2018	SELL	$125.1 - $148.14 $100,330 - $118,808	-802 Reduced 3.06%	25,394 $3.25 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $175,703 - $192,307	1,339 Added 5.39%	26,196 $3.66 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $3.22 Million - $3.37 Million	24,857	24,857 $3.23 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account

Marathon Capital Management Johnson & Johnson Transaction History